Nijhawan Pardeep bought EDSA

February 19, 2026 · Form 4 insider transaction

Nijhawan Pardeep bought 82,236 shares of Edesa Biotech, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 11 days after the transaction.

Direction
Acquired (buy-side)
Shares
82,236
Price
$0.00
Total value
N/A
Role—
SecurityCommon Shares
Transaction codeA: Grant or award
Transaction dateFebruary 19, 2026
Filing dateMarch 2, 2026
Shares owned after595,226
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These RSUs represent awards received in lieu of a portion of Reporting Person's cash bonus earned for the calendar year ending December 31, 2025.

View the original Form 4 on SEC EDGAR